ATR 📈 AptarGroup - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0383361039
ATR: Pumps, Valves, Closures, Dispensers, Inhalers, Elastomers
AptarGroup, Inc. is a leading global player in the design and manufacture of innovative packaging solutions, with a focus on drug delivery systems, consumer product dispensing, and active material science. The company's product portfolio caters to a diverse range of industries, including pharmaceutical, beauty, personal care, home care, and food and beverage. Through its Aptar Pharma, Aptar Beauty, and Aptar Closures segments, AptarGroup provides a broad spectrum of solutions, from pumps for nasal allergy treatments to metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases.
The company's product offerings also include elastomers for injectable primary packaging components, as well as active material science solutions that enhance the performance and functionality of its clients' products. Furthermore, AptarGroup provides dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions sector, underscoring its commitment to innovation and customer satisfaction. With a significant presence in Asia, Europe, Latin America, and North America, AptarGroup has established itself as a trusted partner for companies seeking high-quality packaging solutions that meet the evolving needs of consumers worldwide.
As a company with a rich history dating back to 1992, AptarGroup has consistently demonstrated its ability to adapt and innovate in response to changing market trends and customer requirements. Headquartered in Crystal Lake, Illinois, the company has built a strong reputation for its technical expertise, manufacturing capabilities, and dedication to delivering exceptional customer service. With its common stock listed on the New York Stock Exchange (NYSE) under the ticker symbol ATR, AptarGroup is well-positioned for continued growth and success in the metal, glass, and plastic containers sector, as classified by the Global Industry Classification Standard (GICS) sub-industry.
Additional Sources for ATR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ATR Stock Overview
Market Cap in USD | 10,524m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Metal, Glass & Plastic Containers |
IPO / Inception | 1993-04-21 |
ATR Stock Ratings
Growth 5y | 44.1% |
Fundamental | 49.6% |
Dividend | 55.1% |
Rel. Strength Industry | 346 |
Analysts | 4.67/5 |
Fair Price Momentum | 144.00 USD |
Fair Price DCF | 146.81 USD |
ATR Dividends
Dividend Yield 12m | 1.11% |
Yield on Cost 5y | 1.56% |
Annual Growth 5y | 3.62% |
Payout Consistency | 100.0% |
ATR Growth Ratios
Growth Correlation 3m | -45.3% |
Growth Correlation 12m | 90% |
Growth Correlation 5y | 51.3% |
CAGR 5y | 7.00% |
CAGR/Mean DD 5y | 0.47 |
Sharpe Ratio 12m | 1.09 |
Alpha | 4.45 |
Beta | 0.74 |
Volatility | 20.00% |
Current Volume | 196.9k |
Average Volume 20d | 299.7k |
As of January 15, 2025, the stock is trading at USD 154.61 with a total of 196,911 shares traded.
Over the past week, the price has changed by +0.63%, over one month by -9.58%, over three months by -7.71% and over the past year by +22.80%.
Partly, yes. Based on ValueRay Fundamental Analyses, AptarGroup (NYSE:ATR) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ATR as of January 2025 is 144.00. This means that ATR is currently overvalued and has a potential downside of -6.86%.
AptarGroup has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy ATR.
- Strong Buy: 5
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ATR AptarGroup will be worth about 158 in January 2026. The stock is currently trading at 154.61. This means that the stock has a potential upside of +2.19%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 188 | 21.6% |
Analysts Target Price | 138.5 | -10.4% |
ValueRay Target Price | 158 | 2.2% |